Homogeneous engineered phage populations
AssigneeMassachusetts Institute of Technology
InventorsAngela M. Belcher, Uyanga Tsedev, Fred Lam
Life of this patent
Estimating the term…
Abstract
Provided are engineered phages populations, which are homogeneous in length, as well as methods of making and methods of using such phages. Also provided are engineered chlorotoxin-phages as well as their methods of making and using. The disclosed homogeneous phage populations and chlorotoxin-phages may be used, for example, for treating and/or imaging tumors, such as central nervous system tumors.
Claims43
A homogeneous engineered filamentous phage population, wherein at least 30% of filamentous phages in the phage population have a length within 15% of a selected length value, which is greater than the corresponding wild type filamentous phage length value and up to 10 microns.
A phage comprising chlorotoxin expressed by a coat protein of the phage, wherein the phage is an engineered filamentous phage, which is a part of a homogeneous engineered phage population, wherein at least 30% of phages in the phage population have a length within 15% of a selected length value, which is greater than the corresponding wild type filamentous phage length value and up to 10 microns.
Dependencies are inferred from the claim text.